Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox–an animal model of smallpox

S Parker, NG Chen, S Foster, H Hartzler, E Hembrador… - Antiviral research, 2012 - Elsevier
The human population is currently faced with the potential use of natural or recombinant
variola and monkeypox viruses as biological weapons. Furthermore, the emergence of …
被引用次数：54 相关文章

Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox-an animal model of smallpox.

S Parker, NG Chen, S Foster, H Hartzler… - Antiviral …, 2012 - europepmc.org
The human population is currently faced with the potential use of natural or recombinant
variola and monkeypox viruses as biological weapons. Furthermore, the emergence of …

[引用][C] Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox-An animal model of smallpox

S PARKER, NG CHEN, JE SAGARTZ… - Antiviral …, 2012 - pascal-francis.inist.fr
Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in
respiratory mousepox - An animal model of smallpox CNRS Inist Pascal-Francis CNRS …
[HTML] nih.gov

[HTML][HTML] Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox–An animal model of smallpox

S Parker, NG Chen, S Foster, H Hartzler… - Antiviral …, 2012 - ncbi.nlm.nih.gov
abstract The human population is currently faced with the potential use of natural or
recombinant variola and monkeypox viruses as biological weapons. Furthermore, the …
[PDF] researchgate.net

[PDF][PDF] Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox-an animal model of smallpox

RJ Hruby, R Lanier, G Painter, W Painter, E John… - Antiviral …, 2012 - researchgate.net
The human population is currently faced with the potential use of natural or recombinant
variola and monkeypox viruses as biological weapons. Furthermore, the emergence of …

Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox–An animal model of smallpox

S Parker, NG Chen, S Foster, H Hartzler… - Antiviral Research, 2012 - infona.pl
The human population is currently faced with the potential use of natural or recombinant
variola and monkeypox viruses as biological weapons. Furthermore, the emergence of …

Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox-an animal model of smallpox

S Parker, NG Chen, S Foster, H Hartzler… - Antiviral …, 2012 - pubmed.ncbi.nlm.nih.gov
The human population is currently faced with the potential use of natural or recombinant
variola and monkeypox viruses as biological weapons. Furthermore, the emergence of …
[HTML] nih.gov

[HTML][HTML] Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox-an animal model of smallpox

S Parker, NG Chen, S Foster, H Hartzler… - Antiviral …, 2012 - ncbi.nlm.nih.gov
The human population is currently faced with the potential use of natural or recombinant
variola and monkeypox viruses as biological weapons. Furthermore, the emergence of …

Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox-an animal model of smallpox.

S Parker, NG Chen, S Foster, H Hartzler… - Antiviral …, 2012 - europepmc.org
abstract The human population is currently faced with the potential use of natural or
recombinant variola and monkeypox viruses as biological weapons. Furthermore, the …

[引用][C] Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox-An animal model of smallpox

S PARKER, NG CHEN, S FOSTER, H HARTZLER… - Antiviral research, 2012 - Elsevier